Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune- System-Mediated Protection and Subsequent Long-Term Adaptive Immunity

Chua, Brendon Y.; Wong, Chinn Yi; Mifsud, Edin J.; Edenborough, Kathryn M.; Sekiya, Toshiki; Tan, Amabel C. L.; Mercuri, Francesca; Rockman, Steve; Chen, Weisan; Turner, Stephen J.; Doherty, Peter C.; Kelso, Anne; Brown, Lorena E.; Jackson, David C.

Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune- System-Mediated Protection and Subsequent Long-Term Adaptive Immunity

Chua, Brendon Y.; Wong, Chinn Yi; Mifsud, Edin J. et al.

mBio, 2015, 6(6), e01024-15

Permalink : https://hdl.handle.net/2115/67569

このアイテムのアクセス数:922件（2026-10-06 00:34 集計）

閲覧可能ファイル

ファイル	フォーマット	サイズ	閲覧回数	説明
Chua e al. mBio	pdf	1.44 MB	520

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

アクセス権	open access
URI	https://hdl.handle.net/2115/67569
タイトル	Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune- System-Mediated Protection and Subsequent Long-Term Adaptive Immunity
著者	Chua, Brendon Y. ; Wong, Chinn Yi ; Mifsud, Edin J. ; Edenborough, Kathryn M. ; Sekiya, Toshiki ; Tan, Amabel C. L. ; Mercuri, Francesca ; Rockman, Steve ; Chen, Weisan ; Turner, Stephen J. ; Doherty, Peter C. ; Kelso, Anne ; Brown, Lorena E. ; Jackson, David C.
著者名 Chua, Brendon Y.
著者名 Wong, Chinn Yi
著者名 Mifsud, Edin J.
著者名 Edenborough, Kathryn M.
著者名 Sekiya, Toshiki
著者名 Tan, Amabel C. L.
著者名 Mercuri, Francesca
著者名 Rockman, Steve
著者名 Chen, Weisan
著者名 Turner, Stephen J.
著者名 Doherty, Peter C.
著者名 Kelso, Anne
著者名 Brown, Lorena E.
著者名 Jackson, David C.
言語	英語
発行日	2015-10-27
出版者	American Society for Microbiology
収録物名	mBio
巻(号)	6(6)
ページ	e01024-15
抄録	The continual threat to global health posed by influenza has led to increased efforts to improve the effectiveness of influenza vaccines for use in epidemics and pandemics. We show in this study that formulation of a low dose of inactivated detergent-split influenza vaccine with a Toll-like receptor 2 (TLR2) agonist-based lipopeptide adjuvant (R4Pam2Cys) provides (i) immediate, antigen-independent immunity mediated by the innate immune system and (ii) significant enhancement of antigendependent immunity which exhibits an increased breadth of effector function. Intranasal administration of mice with vaccine formulated with R4Pam2Cys but not vaccine alone provides protection against both homologous and serologically distinct (heterologous) viral strains within a day of administration. Vaccination in the presence of R4Pam2Cys subsequently also induces high levels of systemic IgM, IgG1, and IgG2b antibodies and pulmonary IgA antibodies that inhibit hemagglutination (HA) and neuraminidase (NA) activities of homologous but not heterologous virus. Improved primary virus nucleoprotein (NP)-specific CD8! T cell responses are also induced by the use of R4Pam2Cys and are associated with robust recall responses to provide heterologous protection. These protective effects are demonstrated in wild-type and antibody-deficient animals but not in those depleted of CD8! T cells. Using a contact-dependent virus transmission model, we also found that heterologous virus transmission from vaccinated mice to naive mice is significantly reduced. These results demonstrate the potential of adding a TLR2 agonist to an existing seasonal influenza vaccine to improve its utility by inducing immediate short-term nonspecific antiviral protection and also antigen-specific responses to provide homologous and heterologous immunity.
資源タイプ	学術雑誌論文
出版タイプ	Version of Record
権利情報	Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported
PISSN	2150-7511